510(k) · Cleared
ClearedImmulite 2500 High Sensitivity C-Reactive Protein, Models L5KCRP (200 Tests), L5KCRP (600 Tests)
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Siemens Medical Solutions Diagnostics · NQD Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Cleared on May 2, 2007 as substantially equivalent to K063057 (Diagnostic Products Corporation, 2006) and 1 other predicate after a 22-day review. Its family tree reaches back 3 generations to 1999.
- Decided
- May 2, 2007
- Review
- 22 days
- Class
- Class II
- Product code
- NQD
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 3 generations to K991385 (1999). 4 ancestors in all. No later device cites it as a predicate yet.
- Root · 3 generations backK991385 Dade Behring N High Sensitivity CRP AssayDade Behring, Inc. · 1999
- 2 generations backK033908 N High Sensitivity CRPDade Behring, Inc. · 2004
- 1 generation backK063057 Immulite/Immulite 1000, Immulite 2000 High Sensitivity CRPDiagnostic Products Corporation · 2006
- This deviceK071017 Immulite 2500 High Sensitivity C-Reactive Protein, Models L5KCRP…Siemens Medical Solutions Diagnostics · 2007
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K991385 | Dade Behring N High Sensitivity CRP Assay | Dade Behring, Inc. | 1999 | — |
| −2 | K033908 | N High Sensitivity CRP | Dade Behring, Inc. | 2004 | — |
| −1 | K063057 | Immulite/Immulite 1000, Immulite 2000 High Sensitivity CRP | Diagnostic Products Corporation | 2006 | — |
| 0 (this device) | K071017 | Immulite 2500 High Sensitivity C-Reactive Protein, Models L5KCRP (200 Tests)… | Siemens Medical Solutions Diagnostics | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2000 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in NQD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NQD device
- #1 K260026 Tina-quant Cardiac high sensitivity CRP IIIscore 12.3 · 5 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K063057 | Immulite/Immulite 1000, Immulite 2000 High Sensitivity CRPSummary page 2…tration #: 3005250747 Substantially Equivalent Predicate Device: IMMULITE 2000 High Sensitivity C-Reactive Protein Immunoassay (K063057, K003372) Description of Device: The IMMULITE 2500 High Sensitivity C-Reactive Protein Immunoassay is… | 2006 |
| * | K003372 | Immulite High Sensitivity CRP, Immulite 2000 High Sensitivity CRPSummary page 2…: 3005250747 Substantially Equivalent Predicate Device: IMMULITE 2000 High Sensitivity C-Reactive Protein Immunoassay (K063057, K003372) Description of Device: The IMMULITE 2500 High Sensitivity C-Reactive Protein Immunoassay is… | 2000 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 8 years and passes through 3 companies; a new generation was cleared every 2.9 years on median.
- None of the 4 ancestors has a recall.
How does its category compare?
All NQD devicesNQD Cardiac C-Reactive Protein, Antigen, Antiserum, And Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · NQD
1in 2024
2026 to Oct 25, outlined.
Median 510(k) review, days · NQD
59in 2007
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NQD
2in 2015
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NQD
2in 2025
MAUDE reports naming product code NQD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 3 | 59 | 0 | 1 |
| 2008 | 1 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 1 |
| 2011 | 0 | — | 0 | 5 |
| 2012 | 0 | — | 0 | 2 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 2 | 0 |
| 2016 | 0 | — | 0 | 1 |
| 2017 | 0 | — | 0 | 1 |
| 2018 | 1 | — | 0 | 0 |
| 2019 | 0 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 2 |
| 2022 | 1 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 2 |
| 2024 | 1 | — | 0 | 1 |
| 2025 | 0 | — | 0 | 2 |
| 2026 | 1 | — | 0 | — |
What is it indicated for?
The IMMULITE® 2500 High Sensitivity C-Reactive Protein Immunoassay is intended for use as follows: For in vitro diagnostic use with the IMMULITE 2500 Analyzer - for the quantitative measurement of C-Reactive protein (CRP) in serum or plasma as an aid in the detection and evaluation of infection, tissue injury and inflammatory disorders and associated diseases. Measurements may also be used as an aid in the identification of individuals at risk for future…
Read the full statement (112 words)
The IMMULITE® 2500 High Sensitivity C-Reactive Protein Immunoassay is intended for use as follows:
For in vitro diagnostic use with the IMMULITE 2500 Analyzer - for the quantitative measurement of C-Reactive protein (CRP) in serum or plasma as an aid in the detection and evaluation of infection, tissue injury and inflammatory disorders and associated diseases. Measurements may also be used as an aid in the identification of individuals at risk for future cardiovascular disease. High sensitivity CRP (hsCRP) measurements, when used in conjunction with traditional clinical laboratory evaluation of acute coronary syndrome, may be useful as an independent marker for recurrent events in patients with stable coronary disease or acute coronary syndrome.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K071017 · printed Nov 4, 2026
Cite this page
510(k) Report. “K071017: Immulite 2500 High Sensitivity C-Reactive Protein, Models L5KCRP (200 Tests), L5KCRP (600 Tests).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071017
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026